If youre undergoing cancer treatment, talk to your oncologist before starting ALA
November 22, 2024: Researchers Say More Studies Should Examine GLP-1 Drugs, Like Mounjaro, And Cancer Risks A recent French study published in Endocrine Connections looked into data from patients who used GLP-1 drugs, like Mounjaro, for 1 to 3 years
70 During its meeting in October 2023, The European Medical Association (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) concluded that the available evidence does not support a causal association between the GLP-1RA)exenatide, liraglutide, dulaglutide, semaglutide, and lixisenatideand cancer of the thyroid
E., & Babatunde, T
Evidence-Based Approaches to Safe Semaglutide Dose Reduction Medical literature supports gradual dose tapering rather than abrupt cessation
Chhabra emphasizes the importance of protein and hydration to combat this first-week fatigue